全文获取类型
收费全文 | 1154篇 |
免费 | 144篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 19篇 |
妇产科学 | 11篇 |
基础医学 | 121篇 |
口腔科学 | 74篇 |
临床医学 | 117篇 |
内科学 | 315篇 |
皮肤病学 | 48篇 |
神经病学 | 77篇 |
特种医学 | 209篇 |
外科学 | 113篇 |
综合类 | 17篇 |
预防医学 | 79篇 |
眼科学 | 25篇 |
药学 | 40篇 |
中国医学 | 7篇 |
肿瘤学 | 29篇 |
出版年
2023年 | 17篇 |
2022年 | 20篇 |
2021年 | 38篇 |
2020年 | 36篇 |
2019年 | 29篇 |
2018年 | 59篇 |
2017年 | 33篇 |
2016年 | 36篇 |
2015年 | 47篇 |
2014年 | 60篇 |
2013年 | 79篇 |
2012年 | 57篇 |
2011年 | 61篇 |
2010年 | 68篇 |
2009年 | 69篇 |
2008年 | 49篇 |
2007年 | 49篇 |
2006年 | 42篇 |
2005年 | 27篇 |
2004年 | 32篇 |
2003年 | 23篇 |
2002年 | 19篇 |
2001年 | 22篇 |
2000年 | 21篇 |
1999年 | 22篇 |
1998年 | 23篇 |
1997年 | 26篇 |
1996年 | 19篇 |
1995年 | 15篇 |
1994年 | 9篇 |
1993年 | 17篇 |
1992年 | 8篇 |
1991年 | 5篇 |
1990年 | 11篇 |
1989年 | 22篇 |
1988年 | 18篇 |
1987年 | 13篇 |
1986年 | 10篇 |
1985年 | 18篇 |
1984年 | 6篇 |
1983年 | 4篇 |
1982年 | 10篇 |
1981年 | 6篇 |
1980年 | 10篇 |
1979年 | 6篇 |
1978年 | 3篇 |
1977年 | 6篇 |
1976年 | 8篇 |
1975年 | 5篇 |
1974年 | 3篇 |
排序方式: 共有1307条查询结果,搜索用时 31 毫秒
1.
Iclea Rocha Gama Euclides Marinho Trindade-Filho Suzana Lima Oliveira Nassib Bezerra Bueno Isabelle Tenório Melo Cyro Rego Cabral-Junior Elenita M. Barros Jaqueline A. Galvão Wanessa S. Pereira Raphaela C. Ferreira Bruna R. Domingos Terezinha da Rocha Ataide 《Metabolic brain disease》2015,30(1):93-98
2.
3.
Although allergen avoidance is widely recommended as part of a secondary and tertiary prevention strategy for allergic diseases, a clear-cut demonstration of its effectiveness is still lacking. Ongoing observational secondary prevention cohorts show that sensitisation to mite can be prevented in the short term by allergen avoidance measures, but further follow-up of these children is needed to show if this effect can be sustained, as well as to ascertain its impact on allergic disease. More well-designed trials are still required before we can give any conclusive advice to our patients. Considering the management of allergy, current evidence suggests that interventions in children (either single or multifaceted) may be associated with some beneficial effect on asthma control, but no conclusive evidence exists regarding rhinitis or eczema. Conversely, there is little evidence to support the recommendation of allergen avoidance methods in adults with asthma and rhinitis. There is a need for an adequately designed trial assessing the effects of a multifaceted intervention in this age group. 相似文献
4.
5.
6.
7.
8.
9.
Rui T Marinho Ruth M Pinto Maria L Santos Miguel Carneiro de Moura 《Liver international》2004,24(5):413-418
BACKGROUND: Seroreversion, negativation of anti-hepatitis C virus previously positive, is sometimes found in some chronic hepatitis C-sustained responders (SRs) to antiviral therapy. AIMS: To determine the probability of seroreversion in SR treatment with Interferon and Ribavirin, and lymphocyte T helper (CD4+) reactivity to HCV antigens. METHODS: Thirty SR were followed on average for 54.8 months. Anti-HCV was tested by third generation test. Peripheral blood mononuclear cells (PBMCs) were isolated from venous blood and cultured to evaluate CD4+ proliferation in response to 2 microg/ml of eight HCV recombinant antigens from core, NS3, NS4, NS5 regions. RESULTS: Seroreversion was verified in 23% of patients (7/30), appearing at 47.5+/-24.0 months. The probability of anti-HCV loss in this group was 25% at 56 months after ending therapy. In 57% (4/7), anti-HCV returned to positive. These 7 SR patients with seroreversion also showed weaker CD4+ reactivity in 5% of tests (3/56) than the remaining 23 anti-HCV-positive SRs who showed stronger reactivity in 18% of tests (33/184), P=0.036. CONCLUSIONS: One-quarter of the SR showed seroreversion of anti-HCV and weaker CD4+ specific HCV proliferation than those who remained anti-HCV positive. The data suggest that complete viral eradication is a possible and achievable clinical objective. 相似文献
10.
A Martins H Cortez-Pinto P Marques-Vidal N Mendes S Silva N Fatela H Glória R Marinho I Távora F Ramalho M Carneiro de Moura 《Liver international》2006,26(6):680-687
INTRODUCTION: Hepatocellular carcinoma is a leading cause of death from cancer worldwide. Survival of patients depends on tumor extension and liver function, but yet there is no consensual prognostic model. AIMS: To evaluate the influence on survival of pretreatment parameters (clinico-laboratorial, liver function, tumor extension, Okuda and Cancer of the Liver Italian program (CLIP) staging) and treatment modalities. METHODS: We retrospectively analyzed 207 patients, diagnosed between 1993 and 2003. The initial treatment was: surgery--six patients; radiofrequency ablation--21; percutaneous ethanol injection--29; transarterial chemoembolization--49; tamoxifen--49; supportive care alone--53. Factors determining survival were assessed by Kaplan-Meier method and Cox regression models. RESULTS: Median survival was 24 months. In univariate analysis, Child-Pugh classification and Model for end-stage liver disease (MELD) score, portal vein thrombosis (PVT), tumor size, number of lesions, Okuda and CLIP scores were all associated with prognosis (P < 0.001). Alpha-fetoprotein levels were not predictive of survival. Independent predictors of survival were ascites, bilirubin, PVT and therapeutic modalities (P < 0.001). In early stage hepatocellular carcinoma (HCC), survival was similar for both percutaneous ablation modalities, either radiofrequency or ethanol injection (P = NS). In advanced HCC, survival was better in patients receiving tamoxifen than supportive care alone (P < 0.001). CONCLUSION: This study reinforces the importance of baseline liver function (Child-Pugh classification and MELD score) in the survival of patients with HCC, although staging systems allowed the stratification of patients in different prognostic groups. Ascites, bilirubin and PVT were independent pretreatment predictors of survival. All treatments influenced the patient's outcome, whether in early or advanced stages. 相似文献